Furthermore, genetic studies have revealed the presence of polymorphisms in the genes IL17A / F and IL23R which are associated with inflammatory bowel disease and some cancers such as bladder, breast, uterus and gastric cancer [6, 13–20]. This evidence concerns the gene IL17A and inflammatory bowel disease.